Track Amryt Pharma Plc's inventory ($0) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (April 2023), AMYT shows a inventory of $0. That compares with $120M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AMYT's inventory is now $0 (was $120M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Amryt Pharma Plc is outperforming or lagging.
Tracking AMYT's inventory over time shows whether Amryt Pharma Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $120M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this inventory page, Stockcircle has Amryt Pharma Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $0) with ownership activity and broader fundamentals.
Amryt Pharma Plc's inventory is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.